Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01037790 | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer | completed | Phase 2 | 304 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT03179410 | PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer(PICK-NEPC) | completed | Phase 2 | 15 | Andrew J. Armstrong, MDOTHER | 1 | Mar 5, 2021 |
| clinicaltrials |
| NCT02860819 | Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer | completed | Phase 2 | 15 | National Cancer Institute, SlovakiaOTHER_GOV | 1 | Mar 3, 2021 | clinicaltrials |
| NCT03263780 | High Resolution PET-MRI Before Prostate Cancer HIFU | completed | Phase 2 | 21 | Timothy J. DaskivichOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT02628041 | HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer(HDRvsLDR) | completed | Phase 2 | 30 | CHU de Quebec-Universite LavalOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT02004418 | A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland(PET PRO) | completed | Phase 1 / Phase 2 | 21 | AHS Cancer Control AlbertaOTHER | 1 | Feb 1, 2021 | clinicaltrials |
| NCT01341652 | Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer | completed | Phase 2 | 99 | University of Wisconsin, MadisonOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT01882985 | Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients | completed | Phase 2 | 14 | University of California, IrvineOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT03418324 | Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy | completed | Phase 2 | 11 | Cedars-Sinai Medical CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT02611882 | Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients(PSMA PET) | completed | Phase 2 | 225 | Thomas HopeOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT03348527 | A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer | completed | Phase 2 | 61 | Lidds ABINDUSTRY | 3 | Dec 21, 2020 | clinicaltrials |
| NCT02919111 | Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients(PSMA PreRP) | completed | Phase 2 / Phase 3 | 299 | University of California, San FranciscoOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT01940276 | Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer | completed | Phase 2 | 100 | Duke UniversityOTHER | 1 | Dec 9, 2020 | clinicaltrials |
| NCT01051570 | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel | completed | Phase 2 | 26 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT00428714 | Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 25, 2020 | clinicaltrials |
| NCT02397408 | 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer | completed | Phase 2 | 18 | University of California, San FranciscoOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT02036060 | Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.(ABIDO) | completed | Phase 2 | 119 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Nov 16, 2020 | clinicaltrials |
| NCT01576172 | Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 159 | National Cancer Institute (NCI)NIH | 1 | Nov 12, 2020 | clinicaltrials |
| NCT00466440 | A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients | completed | Phase 2 | 108 | Eli Lilly and CompanyINDUSTRY | 3 | Nov 6, 2020 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT00970203 | Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | completed | Phase 2 | 13 | Roswell Park Cancer InstituteOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT02199197 | Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer | completed | Phase 2 | 49 | University of UtahOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00006365 | External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 138 | Radiation Therapy Oncology GroupNETWORK | 2 | Oct 22, 2020 | clinicaltrials |
| NCT01498978 | Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | completed | Phase 2 | 10 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT03515577 | Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery(PSMA vs AXUMIN) | completed | Phase 2 | 50 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT03675451 | PSMA Imaging of Localized Prostate Cancer | completed | Phase 2 | 20 | Weill Medical College of Cornell UniversityOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02064582 | Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer | completed | Phase 2 | 7 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT01875250 | Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer | completed | Phase 2 | 38 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02059213 | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | completed | Phase 2 | 72 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT01931046 | Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 28 | Momotaro-Gene Inc.INDUSTRY | 1 | Sep 4, 2020 | clinicaltrials |
| NCT00049257 | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 58 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT00514540 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | completed | Phase 2 | 121 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT01637402 | A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer | completed | Phase 2 | 41 | Terence Friedlander, MDOTHER | 1 | Aug 17, 2020 | clinicaltrials |
| NCT01209325 | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | completed | Phase 2 | 149 | AIDS Malignancy ConsortiumNETWORK | 2 | Aug 11, 2020 | clinicaltrials |
| NCT00091390 | Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer | completed | Phase 2 | 129 | Radiation Therapy Oncology GroupNETWORK | 1 | Aug 10, 2020 | clinicaltrials |
| NCT02125357 | Sequencing Abiraterone and Enzalutamide in mCRPC | completed | Phase 2 | 202 | British Columbia Cancer AgencyOTHER | 1 | Aug 7, 2020 | clinicaltrials |
| NCT00054574 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00087035 | Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer | completed | Phase 2 | 1 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT03362359 | Ga-68-PSMA-11 in High-risk Prostate Cancer | completed | Phase 1 / Phase 2 | 173 | German Cancer Research CenterOTHER | 2 | Jul 27, 2020 | clinicaltrials |
| NCT00460031 | Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT02057913 | A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)(VinCaP) | completed | Phase 2 | 22 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT03493997 | Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC)(MISTIC) | completed | Phase 2 | 100 | Study Group for Urogenital Diseases, ItalyOTHER | 4 | Jul 23, 2020 | clinicaltrials |
| NCT02293707 | A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer | completed | Phase 2 | 99 | Laboratoires Leurquin MediolanumINDUSTRY | 2 | Jul 22, 2020 | clinicaltrials |
| NCT01867424 | Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer | completed | Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jul 8, 2020 | clinicaltrials |
| NCT01036594 | Ketoconazole and Dexamethasone in Prostate Cancer(Keto/Dex) | completed | Phase 2 | 32 | University of California, San FranciscoOTHER | 1 | Jun 29, 2020 | clinicaltrials |
| NCT03617588 | 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer(PRONOUNCED) | completed | Phase 2 | 49 | Theragnostics LtdINDUSTRY | 1 | Jun 24, 2020 | clinicaltrials |
| NCT03199872 | RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours | completed | Phase 1 / Phase 2 | 22 | RhoVac APSINDUSTRY | 1 | Jun 9, 2020 | clinicaltrials |
| NCT00105053 | Vaccine Treatment for Hormone Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 8 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT00025116 | ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 40 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 6, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Mar 11, 2021source: clinicaltrials